Combination of Strong MMP-2 and Weak TIMP-2 Immunostainings Is a Significant Prognostic Factor in Endometrial Carcinoma

<table>Effect of MMP-2 and TIMP-2 immunoreactive protein combinations with MMP-2 negative subgroups combined in the cancer-specific survival in endometrioid adenocarcinoma patients.</table>

Disease Markers

fig3

Figure 3

Figure 3: Combination of Strong MMP-2 and Weak TIMP-2 Immunostainings Is a Significant Prognostic Factor in Endometrial Carcinoma 